Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Adalimumab-Fkjp(Cf) Pen(Adalimumab-Fkjp)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$182K

Medicare cost, 2024

Medicare drug plans spent $182,096 on Adalimumab-Fkjp(Cf) Pen (adalimumab-fkjp) in 2024, for 169 prescriptions and refills filled by 43 patients. Spending rose 308% from 2023 to 2024. California accounts for the most spending ($25,453, 14% of the total).

Medicare cost, 2024

$182K

+307.8% from 2023

Prescriptions

169

$1,077.49 per claim

Patients

43

43 prescribers

Total spending, 2024

$182K

$4,234.80 per patient

Questions and answers

How much does Medicare spend on Adalimumab-Fkjp(Cf) Pen?

Medicare prescription drug plans paid $182K for Adalimumab-Fkjp(Cf) Pen in 2024, for 169 prescriptions and refills to 43 patients (up 307.8% from 2023). The average cost per claim was $1,077.49.

Which state spends the most on Adalimumab-Fkjp(Cf) Pen?

California had the highest Medicare cost for Adalimumab-Fkjp(Cf) Pen in 2024: $25K for 24 claims, followed by Oregon ($22K).

Who prescribes Adalimumab-Fkjp(Cf) Pen the most?

Christopher S Cutler, gastroenterology in Sandy, UT, had the highest Medicare cost for Adalimumab-Fkjp(Cf) Pen in 2024: 13 claims costing $14K.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Adalimumab-Fkjp(Cf) Pen was $182K in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Adalimumab-Fkjp(Cf) Pen, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Christopher S Cutler Sandy, UTGastroenterology13Under 11$14K
James R Rummel Jr. Hermitage, PAFamily Practice11Under 11$11K
Fernando J Pardo-Ruiz Deming, NMInternal Medicine12Under 11$11K
Anish A Sheth Princeton, NJGastroenterology11Under 11$11K

Prescriber data by year

YearPrescribersClaimsPatientsCost
2023113111$45K
20244316943$182K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Mylan Spec/BiocVTRS logoVTRS86$95K
Biocon BiologicBIOCON.NS logoBIOCON.NS83$87K

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube